Baolingbao Biology Co Ltd Working Capital to Net Assets Ratio
Baolingbao Biology Co Ltd working capital to net assets ratio. Baolingbao Biology Co Ltd (002286) has a Working Capital to Net Assets ratio of 19.6% as of March 2026. Working capital of CN¥450.98 Million (current assets of CN¥1.02 Billion minus current liabilities of CN¥569.73 Million) is measured against net assets of CN¥2.30 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Baolingbao Biology Co Ltd (2006–2025)
Working capital to net assets ratio of Baolingbao Biology Co Ltd from 2006 to 2025. This chart shows how Baolingbao Biology Co Ltd's Working Capital to Net Assets ratio has evolved across 20 annual periods from 2006 to 2025. As of March 2026, the ratio stands at 19.6%, reflecting working capital of CN¥450.98 Million against net assets of CN¥2.30 Billion CNY. Explore investment intensity of Baolingbao Biology Co Ltd to see how much of total assets are deployed in long-term investments.
Baolingbao Biology Co Ltd Working Capital to Net Assets Ratio by Year (2006–2025)
Baolingbao Biology Co Ltd working capital to net assets ratio by year from 2006 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Baolingbao Biology Co Ltd from 2006 to 2025, covering 20 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see balance sheet size of Baolingbao Biology Co Ltd.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 19.2% | CN¥429.56 Million | CN¥2.23 Billion | CN¥914.30 Million | CN¥484.74 Million | ▲ +7.8 pp |
| 2024 | 11.5% | CN¥234.12 Million | CN¥2.04 Billion | CN¥810.22 Million | CN¥576.10 Million | ▲ +0.9 pp |
| 2023 | 10.6% | CN¥209.39 Million | CN¥1.98 Billion | CN¥785.87 Million | CN¥576.47 Million | ▼ -1.2 pp |
| 2022 | 11.8% | CN¥236.32 Million | CN¥2.00 Billion | CN¥995.78 Million | CN¥759.46 Million | ▲ +1.0 pp |
| 2021 | 10.8% | CN¥195.05 Million | CN¥1.81 Billion | CN¥1.31 Billion | CN¥1.12 Billion | ▲ +7.5 pp |
| 2020 | 3.2% | CN¥51.75 Million | CN¥1.60 Billion | CN¥1.01 Billion | CN¥956.41 Million | ▲ +0.2 pp |
| 2019 | 3.0% | CN¥46.84 Million | CN¥1.57 Billion | CN¥945.57 Million | CN¥898.73 Million | ▲ +6.7 pp |
| 2018 | -3.8% | CN¥-57.97 Million | CN¥1.54 Billion | CN¥926.55 Million | CN¥984.52 Million | ▼ -17.4 pp |
| 2017 | 13.6% | CN¥207.98 Million | CN¥1.53 Billion | CN¥756.91 Million | CN¥548.93 Million | ▼ -1.9 pp |
| 2016 | 15.6% | CN¥235.05 Million | CN¥1.51 Billion | CN¥622.87 Million | CN¥387.82 Million | ▲ +0.6 pp |
| 2015 | 15.0% | CN¥222.23 Million | CN¥1.48 Billion | CN¥624.97 Million | CN¥402.74 Million | ▼ -11.0 pp |
| 2014 | 26.0% | CN¥376.97 Million | CN¥1.45 Billion | CN¥657.46 Million | CN¥280.48 Million | ▼ -15.2 pp |
| 2013 | 41.2% | CN¥591.58 Million | CN¥1.44 Billion | CN¥797.86 Million | CN¥206.27 Million | ▲ +28.3 pp |
| 2012 | 12.9% | CN¥105.73 Million | CN¥817.45 Million | CN¥373.89 Million | CN¥268.15 Million | ▲ +5.5 pp |
| 2011 | 7.4% | CN¥56.50 Million | CN¥760.53 Million | CN¥389.31 Million | CN¥332.80 Million | ▼ -8.6 pp |
| 2010 | 16.0% | CN¥112.57 Million | CN¥703.11 Million | CN¥403.93 Million | CN¥291.36 Million | ▼ -10.8 pp |
| 2009 | 26.8% | CN¥177.45 Million | CN¥662.61 Million | CN¥538.40 Million | CN¥360.95 Million | ▲ +36.9 pp |
| 2008 | -10.2% | CN¥-24.21 Million | CN¥238.05 Million | CN¥258.16 Million | CN¥282.36 Million | ▲ +25.7 pp |
| 2007 | -35.9% | CN¥-69.36 Million | CN¥193.28 Million | CN¥167.57 Million | CN¥236.93 Million | ▲ +66.6 pp |
| 2006 | -102.5% | CN¥-115.37 Million | CN¥112.53 Million | CN¥254.94 Million | CN¥370.31 Million | — |